In the UK Biobank database, CLPTM1L was significantly associated with various cancer phenotypes, including lung, upper digestive tract, pancreatic, testicular, nasopharyngeal, and oral cancer. This evidence concerns the gene CLPTM1L and lip and oral cavity carcinoma.